Matthew L. Wein, J.D.

Matthew L. Wein, J.D.

General Counsel, Compliance Officer, Head of BD&L and Corporate SecretaryatMetagenomi Therapeutics· In proxies 2024–2025

Pay in FY2025Metagenomi Therapeutics stock -55.1% the same year

Matthew L. Wein, J.D. was paid $756.4K in FY2025 (Dec). Metagenomi Therapeutics stock fell 55.1% that year.

Pay$100 in the stock at the end of FY24 → $45
Pay is from the Summary Compensation Table of each Metagenomi Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Metagenomi TherapeuticsPublic company · 2 yr
    • General Counsel, Compliance Officer, Head of BD&L and Corporate Secretary2024 – Present · 2 yrStock in role -92%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?